Uniting Efforts For Innovation, Access and Delivery: A Global Dialogue
Achieving the health-related goals and targets of the 2030 Agenda for Sustainable Development, including universal health coverage, requires greater collaboration between stakeholders involved in the discovery, development and delivery of health technologies.
Since 2013, thanks to the generous support of the Government of Japan, the Global Health Innovative Technology Fund (GHIT Fund) and the UNDP-led Access and Delivery Partnership (ADP) have been working on two sides of the same coin: driving health technology innovation for TB, malaria, NTDs and other neglected diseases on the one hand, and strengthening health systems to promote access and delivery, on the other.
Against this background and as part of the scale up phase of this ongoing collaboration, the Government of Japan, the GHIT Fund and ADP united to convene Uniting Efforts for Innovation, Access and Delivery: A Global Dialogue.
Uniting Efforts for Innovation, Access and Delivery: A Global Dialogue brought together a global network of biomedical R&D funders, product development partners and innovators, and organizations and platforms focused on the access and delivery of health technologies for key unmet health needs – including malaria, tuberculosis and neglected tropical diseases.
The purpose of the meeting was to initiative a global dialogue between key stakeholders that are needed to accelerate both innovation, access and delivery of essential health technologies, providing an opportunity for sharing of experiences, common challenges, and knowledge, identify best practices and explore opportunities for potential future collaboration and dialogue.
This meeting and initiative aims to be useful to a broad variety of stakeholders that usually do not have pre-established forums for cross-sectoral dialogue. Participants are expected to include representatives from:
Select R&D funders, PDPs and research institutions, as well as access and delivery stakeholders working on or interested in diseases that predominantly affect low and middle-income countries.
Government representatives from low and middle-income countries, including procurement and regulatory authorities within Ministers of Health, Ministries of Science and Technology and research institutes.
Select patients, civil society, academics, private sector representatives, experts and thought and opinion leaders.
The Global Dialogue took place in Bangkok in January 2019. The invite only event began with a formal evening reception on Wednesday, 30 January and was followed by a full-day working meeting on Thursday, 31 January.